U.S. Specialty Stores Stock News

EPAM Systems, Inc. previously proposed amending its Fourth Amended and Restated Certificate of Incorporation to allow shareholders to call special meetings, alongside urging investors in its April 6, 2026 definitive proxy filing to vote against a separate shareholder proposal seeking a 10% ownership threshold for calling such meetings. This contrast between management’s preferred approach and an activist-backed, lower threshold highlights an evolving power balance over how quickly investors...

Wondering whether Onto Innovation at around US$290.76 is offering good value or stretched pricing? This article breaks down what the current market is implying about the stock. The share price context includes a 13.1% return over the last 7 days, 45.3% over 30 days, 75.3% year to date, 152.9% over 1 year, 251.5% over 3 years and 315.5% over 5 years. These moves sit against a backdrop where investors are paying closer attention to semiconductor suppliers tied to advanced manufacturing and...

Earnings, buybacks and credit quality in focus FB Financial (FBK) just reported first quarter 2026 results, with higher net interest income and net income than a year ago, alongside an update on share repurchases and credit costs. See our latest analysis for FB Financial. The latest results, share repurchases and relatively contained credit costs come against a backdrop of a 6.05% 1 month share price return and a 34.99% 1 year total shareholder return. This suggests momentum has been uneven...

Moderna recently presented positive Phase 1/2 data for its investigational cancer antigen therapy mRNA-4359 in combination with pembrolizumab in advanced melanoma, and the U.S. FDA granted the regimen Fast Track designation for a specific PD-L1 positive melanoma population. The strong early response and disease control rates, together with regulatory acceleration, highlight how Moderna is extending its mRNA platform beyond infectious disease vaccines into oncology. We’ll now examine how the...

Generac Holdings (GNRC) recently announced a collaboration with CPower Energy to deploy distributed generation across the PJM market, focusing on battery storage, generators and microgrids for commercial and industrial customers. See our latest analysis for Generac Holdings. The latest partnership news comes as Generac’s share price, now at $212.10, has seen a 6.42% 1 month share price return and a 31.86% 3 month share price return, with 1 year total shareholder return of 89.85% pointing to...

Astronics (NasdaqGS:ATRO) has introduced its new EmPower Qi2 Wireless Charging Module for aircraft cabins, galleys, and crew rest areas. The module supports the latest Qi enabled and MagSafe compatible devices and is designed for rapid maintenance and compliance with aviation standards. Astronics focuses on aerospace and defense electronics, with cabin power and connectivity as a core part of its business. The EmPower Qi2 Wireless Charging Module fits directly into that franchise and aims...

Aktis Oncology (NasdaqGS: AKTS) has appointed Dr. Glenn Gormley as an independent director to its Board. Dr. Gormley will also serve as co-chair of a newly formed Science and Technology Committee. The company announced upcoming departures of two current Board members as part of this transition. Aktis Oncology, trading on NasdaqGS under the ticker AKTS, recently closed at $20.25. The stock is up 20.0% over the past week and 14.4% over the past 30 days, while the year-to-date return stands at...

Earlier in April 2026, Brinker International’s Chili’s brand introduced new Big Crispy and Spicy Big Crispy chicken sandwiches within its 3 For Me value combo, backed by upcoming television advertising and a New York City pop-up aimed directly at fast-food competitors. This move highlights Chili’s effort to fuse value-oriented bundles with more premium chicken sandwich options, seeking to protect margins while challenging quick-service chains for traffic. We’ll now examine how Chili’s...

If you are wondering whether Cohu at around US$41.26 is still reasonably priced after a strong run, this article walks through what the current numbers say about value. The stock has posted returns of 10.5% over the last 7 days, 39.8% over 30 days, 67.7% year to date, and 193.5% over 1 year, which has put valuation firmly in focus for many investors. Recent coverage has highlighted Cohu's position within the semiconductor space and how sentiment around the industry has influenced stocks with...

Home renovation activity is driving fresh interest in Rocket Mortgage cash-out refinances linked to Rocket Companies (NYSE:RKT). A recent survey points to many Americans choosing to renovate instead of buying or moving, with a meaningful share using cash-out refinance products to fund projects. This shift in housing behavior is influencing demand patterns across Rocket's lending offerings and the broader U.S. housing market. For Rocket Companies, which operates Rocket Mortgage and other...

Ally Financial (NYSE:ALLY) reported first quarter results featuring a 90% jump in adjusted EPS, record origination volumes, and strong digital banking growth. The company highlighted progress on its Focus Forward transformation, with higher auto loan activity and digital engagement contributing to the quarter. These developments come after prior business divestitures, as Ally continues to concentrate on core auto finance and digital banking operations. For investors tracking NYSE:ALLY, the...

PDD Holdings (NasdaqGS:PDD) has reached a resolution to a major regulatory investigation in China. As part of the conclusion, authorities imposed a fine on the company, closing out a significant enforcement action. The outcome removes a key source of uncertainty that had been hanging over PDD Holdings. PDD Holdings, the owner of e commerce platform Pinduoduo and cross border marketplace Temu, operates at the center of China’s large online retail and discount shopping market. The company...

If you are wondering whether Limbach Holdings at around US$93.56 is offering good value or stretching expectations, you are not alone. The stock has posted returns of 13.3% over the last 7 days, 32.7% over 30 days, 18.3% year to date, 8.0% over 1 year and a very large gain over 5 years, which naturally raises questions about what is already priced in and how much risk you are taking on at current levels. Recent coverage has focused on Limbach Holdings as investors reassess contractors and...

Wondering if AT&T at around US$26.51 is a bargain or fairly priced right now? This article breaks down the numbers so you can judge the value for yourself. The stock has returned 0.2% over the last 7 days, 7.9% year to date, and 1.9% over the last year, with a 6.4% decline over the past month and longer term returns of 71.1% over 3 years and 49.9% over 5 years, which may hint at shifting views on its risk and reward profile. Recent attention on AT&T has centered on its position in the US...

Peloton Interactive stock: recent move and context Peloton Interactive (PTON) has drawn attention after a one-month return of 32.8%, contrasting with a three-month total return decline of 19.4% and a five-year total return decline of 94.95%. See our latest analysis for Peloton Interactive. At a share price of $5.10, Peloton’s recent 7 day share price return of 10.4% and 30 day share price return of 32.8% contrast with a weaker one year total shareholder return of a 5.4% decline, suggesting...

If you are wondering whether Viasat’s share price still offers value after a strong run, it helps to step back and look at what the current market price might be implying about the business. Viasat last closed at US$62.85, with returns of 11.7% over the past 7 days, 35.5% over the past 30 days, 67.0% year to date, and a very large gain over the last year, with the 1-year return around 7x. Recent headlines around Viasat have focused on its role in satellite communications, large contracts,...

Wondering whether Dave at around US$250.71 is still offering value, or if most of the upside is already priced in. The stock has posted returns of 35.2% over 7 days, 19.5% over 30 days, 14.2% year to date and 197.5% over 1 year, with a very large 3 year return of about 44x. Recent coverage around Dave has focused on its sharp share price swings and what that might signal about changing expectations for the business. This context is important when you are trying to separate temporary market...

New clinical data on BD's PureWick Urine Collection System reports benefits for sleep and comfort in women with nighttime urinary incontinence. Pivotal trial results for BD's Liverty TIPS Stent Graft for portal hypertension received a first major scientific meeting presentation. Both updates highlight patient focused device development in home urinary care and interventional liver disease. Becton Dickinson, NYSE:BDX, is drawing fresh attention as it surfaces new clinical data around two...

Zoetis Inc. recently opposed a shareholder proposal on written-consent rights in its definitive proxy filing, even as CEO Kristin C. Peck highlighted the company’s outlook at the Semafor World Economy 2026 conference in Washington, D.C. Together with analyst expectations for higher Q1 2026 earnings and continued consensus confidence, these governance and communication moves are sharpening investor focus on Zoetis’s long-term growth story. We’ll now examine how the anticipated Q1 earnings...

In April 2026, Revvity, Inc. showcased a suite of research-use-only oncology tools at the AACR Annual Meeting and introduced its cloud-native Signals BioDesign molecular cloning software at Bio-IT World, highlighting integrated instruments, reagents, and AI-enabled analytics aimed at streamlining cancer and biologics research workflows. By linking advanced imaging, automation, and cloud software within unified research ecosystems, Revvity is positioning its oncology and biologics platforms...

If you are wondering whether NewMarket at around US$634 per share still offers fair value or is starting to look stretched, the key is to understand what the current price actually reflects. The stock has seen mixed recent returns, with 0.9% over the last week, 3.2% over the past month, a 7.8% decline year to date, and 14.4% over the last year, alongside very large gains over 3 and 5 years. Recent coverage has focused on NewMarket's position in the Chemicals sector and how its longer term...

In recent days, Bath & Body Works has acknowledged ongoing weak same-store sales and falling earnings per share, while scaling back its laundry category and shifting resources toward core products and a stronger digital presence, including a curated launch on Amazon. This refocus highlights how management is reallocating marketing and product development spending away from underperforming experiments to reinforce the brand’s main categories and online reach. We’ll now examine how Bath & Body...

Recent moves in Regions Financial might have you wondering whether the current share price still leaves room for value or if most of the opportunity has already been priced in. Over shorter periods, the stock has recorded returns of 2.3% over 7 days, 10.9% over 30 days, 2.1% year to date, 51.8% over 1 year, 75.6% over 3 years and 67.0% over 5 years. This gives useful context before looking at what the business might be worth today. Alongside these returns, investors have had an ongoing flow...

Why AES (AES) is on investors’ radar today AES (AES) is back in focus after recent trading left the shares around US$14.47, drawing attention to how the stock’s current pricing lines up with its fundamentals and past year total return. See our latest analysis for AES. Recent trading around US$14.47 comes after a modest 30 day share price return of 2.62%, set against a much stronger 1 year total shareholder return of 50.27% and weaker 3 and 5 year total shareholder returns. Taken together,...